Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Study of the Safety and Effectiveness of ADX-N05 in the Treatment of Excessive Daytime Sleepiness

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Aerial BioPharma, LLC
ClinicalTrials.gov Identifier:
NCT01485770
First received: December 2, 2011
Last updated: March 8, 2013
Last verified: March 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2012
  Primary Completion Date: May 2012 (Final data collection date for primary outcome measure)
  Certification or Request for Extension to Delay Results Received: March 8, 2013